Manuela A. Santos

Av. Rovisco Pais 1
Lisbon, 1049001, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Lead optimization of rivastigmine-like hybrids: Impact of nitro group and halogen substitution on multi-target anti-Alzheimer's activity.

Lead optimization of rivastigmine-like hybrids: Impact of nitro group and halogen substitution on multi-target anti-Alzheimer's activity.

Journal: Bioorganic & medicinal chemistry

Published: June 22, 2026

Prevalence of epilepsy in Portugal: An epidemiologic population-based study (EPIPORT).

Prevalence of epilepsy in Portugal: An epidemiologic population-based study (EPIPORT).

Journal: Epilepsy research

Published: March 23, 2026

Emerging Roles of Rivastigmine Derivatives Bearing Antioxidant Motifs as Multi-Target Agents for the Management of Neurodegenerative Diseases.

Emerging Roles of Rivastigmine Derivatives Bearing Antioxidant Motifs as Multi-Target Agents for the Management of Neurodegenerative Diseases.

Journal: International journal of molecular sciences

Published: March 16, 2026

Rivastigmine Templates with Antioxidant Motifs-A Medicinal Chemist's Toolbox Towards New Multipotent AD Drugs.

Rivastigmine Templates with Antioxidant Motifs-A Medicinal Chemist's Toolbox Towards New Multipotent AD Drugs.

Journal: Antioxidants (Basel, Switzerland)

Published: May 14, 2025

Gadolinium Complex with Tris-Hydroxypyridinone as an Input for New Imaging Probes: Thermodynamic Stability, Molecular Modeling and Biodistribution.

Gadolinium Complex with Tris-Hydroxypyridinone as an Input for New Imaging Probes: Thermodynamic Stability, Molecular Modeling and Biodistribution.

Journal: Molecules (Basel, Switzerland)

Published: February 18, 2025

Editorial on Special Issue "The Therapy of Alzheimer's Disease: Towards a New Generation of Drugs".

Editorial on Special Issue "The Therapy of Alzheimer's Disease: Towards a New Generation of Drugs".

Journal: Pharmaceutics

Published: January 20, 2025

Correction: Severe Scoliosis As the Clue for an Early Onset Myopathy, Areflexia, Respiratory Distress, and Dysphagia (EMARDD) Diagnosis During Childhood: A Case Report.

Correction: Severe Scoliosis As the Clue for an Early Onset Myopathy, Areflexia, Respiratory Distress, and Dysphagia (EMARDD) Diagnosis During Childhood: A Case Report.

Journal: Cureus

Published: December 10, 2024

Severe Scoliosis As the Clue for an Early Onset Myopathy, Areflexia, Respiratory Distress, and Dysphagia (EMARDD) Diagnosis During Childhood: A Case Report.

Severe Scoliosis As the Clue for an Early Onset Myopathy, Areflexia, Respiratory Distress, and Dysphagia (EMARDD) Diagnosis During Childhood: A Case Report.

Journal: Cureus

Published: December 02, 2024

Linguistic validation of a questionnaire for assessing the prevalence of epilepsy in Portugal.

Linguistic validation of a questionnaire for assessing the prevalence of epilepsy in Portugal.

Journal: Epilepsy & behavior : E&B

Published: November 28, 2024

Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer's drug candidates.

Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer's drug candidates.

Journal: Bioorganic chemistry

Published: September 10, 2024

Exploiting the potential of rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases.

Exploiting the potential of rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases.

Journal: Journal of inorganic biochemistry

Published: July 01, 2024

Multicentric Study on the Diagnostic of Neuromuscular Diseases in Children with High Creatinine Phosphokinase Levels.

Multicentric Study on the Diagnostic of Neuromuscular Diseases in Children with High Creatinine Phosphokinase Levels.

Journal: Children (Basel, Switzerland)

Published: June 03, 2024

Showing 1-12 of 83

Last Updated: 09/26/2026